Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer.

Yuxin MuYanchun MengYiqun DuXiaojun LiuJian Zhang

Published in: Thoracic cancer (2023)

Our data demonstrated the clinical benefit of anti-HER2 treatment in Chinese breast cancer patients harboring HER2 mutation and/or HER2 fusion. The value of immunotherapy and treatment selection among individual HER2 variants needs further study.

Keyphrases

copy number
young adults
deep learning
data analysis